<<

Acta Neuropsychiatrica 2009: 21: 213 All rights reserved © 2009 John Wiley & Sons A/S DOI: 10.1111/j.1601-5215.2009.00420.x ACTA NEUROPSYCHIATRICA

Editorial Six decades since Cade’s six

The title of this editorial describes John Cade’s to be effective in treating many facets of mood disor- contribution to neuropsychiatry as a ‘cricketing six’, ders, both unipolar and bipolar, and is the only agent and the question arises whether we have in any that is protective against suicide. Further, its neu- way bettered this score. Sixty years ago John Cade roprotective properties hold much promise both for published his seminal paper in the Medical Journal future treatments and for better understanding mood of Australia (1). In this, he described the effects of disorders. Therefore, to celebrate the achievements on a total of 10 patients. The patients are of lithium and the many that contributed to its dis- sometimes recounted as having but covery this issue is dedicated to research pertaining in fact one was schizoaffective and, of the remaining to bipolar disorder. Two wonderful reviews examine nine, three had chronic whilst six had mania very different aspects of mood disorders specifically, with an episodic pattern. nutrition, mood and behaviour and a model of bipolar He had observed that lithium administration pro- disorder based on neuroimaging findings. Then a fur- duced a profound effect on the mental state of these ther two original articles report on studies conducted patients, usually within a matter of days, and that in bipolar patients using novel interventions. when lithium treatment was stopped these benefits Together these articles show the diversity and were lost, but that the effect could be regained by complexity of today’s research into all facets of reinstituting the medication. Indeed, affective symp- bipolar disorder and how our understanding of the toms improved in all the patients and the majority had illness is rapidly advancing. However, in practice a marked improvement in functioning. Cade deduced we have yet to improve upon lithium and the many from this that lithium had a specific antimanic action promising findings from basic science research await and suggested that perhaps mania resulted from a translation into clinical treatments. ‘deficiency in the body of lithium ions’. Reading this today, in an era of randomised con- Professor Gin S. Malhi trolled trials and meta-analyses of clinical studies, it CADE Clinic, Discipline of Psychological Medicine, is difficult to comprehend how such a humble report University of Sydney, Sydney, Australia. achieved such significant impact. In reality lithium E-mail: [email protected] had a slow start and took some years to be tested further. Worldwide, its use as a potential treatment varied considerably and its uptake was resisted in the United States, for many years. However, with time References lithium has ‘matured’ and gradually its richness is 1. Cade JFJ. Lithium salts in the treatment of psychotic being fully realized. Indeed, lithium has been shown excitement. Med J Aust 1949;2:349–352.

213 Downloaded from https://www.cambridge.org/core. IP address: 170.106.35.234, on 24 Sep 2021 at 04:02:02, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1111/j.1601-5215.2009.00420.x